Jane Street’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-113,150
Closed -$344K 6958
2024
Q4
$344K Sell
113,150
-455,504
-80% -$1.38M ﹤0.01% 4471
2024
Q3
$2.95M Buy
568,654
+404,741
+247% +$2.1M ﹤0.01% 1915
2024
Q2
$421K Buy
163,913
+24,012
+17% +$61.7K ﹤0.01% 4692
2024
Q1
$688K Buy
139,901
+82,716
+145% +$407K ﹤0.01% 3680
2023
Q4
$503K Sell
57,185
-89,797
-61% -$789K ﹤0.01% 4098
2023
Q3
$1.69M Buy
146,982
+34,995
+31% +$401K ﹤0.01% 2408
2023
Q2
$2.83M Sell
111,987
-162,812
-59% -$4.12M ﹤0.01% 2045
2023
Q1
$8.85M Buy
274,799
+249,255
+976% +$8.03M ﹤0.01% 797
2022
Q4
$472K Sell
25,544
-221,521
-90% -$4.09M ﹤0.01% 3463
2022
Q3
$6.67M Buy
247,065
+206,702
+512% +$5.58M ﹤0.01% 932
2022
Q2
$558K Sell
40,363
-59,973
-60% -$829K ﹤0.01% 3436
2022
Q1
$1.96M Buy
100,336
+70,636
+238% +$1.38M ﹤0.01% 2178
2021
Q4
$485K Sell
29,700
-6,261
-17% -$102K ﹤0.01% 3504
2021
Q3
$1M Buy
+35,961
New +$1M ﹤0.01% 2638
2021
Q2
Hold
0
5887
2021
Q1
Sell
-36,855
Closed -$1.05M 5475
2020
Q4
$1.05M Buy
36,855
+12,823
+53% +$364K ﹤0.01% 2065
2020
Q3
$605K Buy
+24,032
New +$605K ﹤0.01% 2262
2019
Q2
Sell
-20,029
Closed -$316K 4092
2019
Q1
$316K Buy
20,029
+6,441
+47% +$102K ﹤0.01% 2661
2018
Q4
$274K Buy
+13,588
New +$274K ﹤0.01% 2609
2018
Q1
Sell
-19,172
Closed -$685K 3692
2017
Q4
$685K Buy
+19,172
New +$685K ﹤0.01% 1752
2016
Q1
Hold
0
3123
2015
Q4
Hold
0
3113